UBS raised the firm’s price target on Stryker (SYK) to $400 from $386 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Walmart downgraded, Etsy upgraded: Wall Street’s top analyst calls
- Stryker initiated with an Outperform at William Blair
- Stryker: Expanding Breast Reconstruction Leadership Warrants Premium Valuation and Buy Rating
- Stryker price target raised to $469 from $462 at Barclays
- Stryker (SYK) Earnings Call Highlights Growth and Resilience